244 related articles for article (PubMed ID: 30780005)
1. Interleukin-33 prevents the development of autoimmune diabetes in NOD mice.
Lu J; Liang Y; Zhao J; Meng H; Zhang X
Int Immunopharmacol; 2019 May; 70():9-15. PubMed ID: 30780005
[TBL] [Abstract][Full Text] [Related]
2. Vaccination with a co-expression DNA plasmid containing GAD65 fragment gene and IL-10 gene induces regulatory CD4(+) T cells that prevent experimental autoimmune diabetes.
Liu X; Zhang S; Li X; Zheng P; Hu F; Zhou Z
Diabetes Metab Res Rev; 2016 Sep; 32(6):522-33. PubMed ID: 26797873
[TBL] [Abstract][Full Text] [Related]
3. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
[TBL] [Abstract][Full Text] [Related]
4. Total coumarins from Urtica dentata Hand prevent murine autoimmune diabetes via suppression of the TLR4-signaling pathways.
Wang J; Lu J; Lan Y; Zhou H; Li W; Xiang M
J Ethnopharmacol; 2013 Mar; 146(1):379-92. PubMed ID: 23340441
[TBL] [Abstract][Full Text] [Related]
5. IL-33 Prevents MLD-STZ Induction of Diabetes and Attenuate Insulitis in Prediabetic NOD Mice.
Pavlovic S; Petrovic I; Jovicic N; Ljujic B; Miletic Kovacevic M; Arsenijevic N; Lukic ML
Front Immunol; 2018; 9():2646. PubMed ID: 30498495
[TBL] [Abstract][Full Text] [Related]
6. Reduced interleukin-2 responsiveness impairs the ability of Treg cells to compete for IL-2 in nonobese diabetic mice.
James CR; Buckle I; Muscate F; Otsuka M; Nakao M; Oon JSh; Steptoe RJ; Thomas R; Hamilton-Williams EE
Immunol Cell Biol; 2016 May; 94(5):509-19. PubMed ID: 26763864
[TBL] [Abstract][Full Text] [Related]
7. Impact of protective IL-2 allelic variants on CD4+ Foxp3+ regulatory T cell function in situ and resistance to autoimmune diabetes in NOD mice.
Sgouroudis E; Albanese A; Piccirillo CA
J Immunol; 2008 Nov; 181(9):6283-92. PubMed ID: 18941219
[TBL] [Abstract][Full Text] [Related]
8. Surge in regulatory T cells does not prevent onset of hyperglycemia in NOD mice: immune profiles do not correlate with disease severity.
Kaminitz A; Mizrahi K; Askenasy N
Autoimmunity; 2014 Mar; 47(2):105-12. PubMed ID: 24328490
[TBL] [Abstract][Full Text] [Related]
9. KLRG1 expression identifies short-lived Foxp3
Kornete M; Mason E; Istomine R; Piccirillo CA
Autoimmunity; 2017 Sep; 50(6):354-362. PubMed ID: 28850267
[TBL] [Abstract][Full Text] [Related]
10. Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T cells.
Mellanby RJ; Thomas D; Phillips JM; Cooke A
Immunology; 2007 May; 121(1):15-28. PubMed ID: 17428252
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-10 gene transfer into insulin-producing β cells protects against diabetes in non-obese diabetic mice.
Xu A; Zhu W; Li T; Li X; Cheng J; Li C; Yi P; Liu L
Mol Med Rep; 2015 Sep; 12(3):3881-3889. PubMed ID: 25998958
[TBL] [Abstract][Full Text] [Related]
12. Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice.
Tarbell KV; Petit L; Zuo X; Toy P; Luo X; Mqadmi A; Yang H; Suthanthiran M; Mojsov S; Steinman RM
J Exp Med; 2007 Jan; 204(1):191-201. PubMed ID: 17210729
[TBL] [Abstract][Full Text] [Related]
13. Antidiabetic and Immunoregulatory Activities of Extract of
Lin CH; Kuo YH; Shih CC
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373070
[TBL] [Abstract][Full Text] [Related]
14. Human amylin induces CD4+Foxp3+ regulatory T cells in the protection from autoimmune diabetes.
Zhang XX; Qiao YC; Li W; Zou X; Chen YL; Shen J; Liao QY; Zhang QJ; He L; Zhao HL
Immunol Res; 2018 Feb; 66(1):179-186. PubMed ID: 28983871
[TBL] [Abstract][Full Text] [Related]
15. IL-33 dysregulates regulatory T cells and impairs established immunologic tolerance in the lungs.
Chen CC; Kobayashi T; Iijima K; Hsu FC; Kita H
J Allergy Clin Immunol; 2017 Nov; 140(5):1351-1363.e7. PubMed ID: 28196763
[TBL] [Abstract][Full Text] [Related]
16. Targeting of IL-2 receptor with a caspase fusion protein disrupts autoimmunity in prediabetic and diabetic NOD mice.
Yarkoni S; Kaminitz A; Sagiv Y; Askenasy N
Diabetologia; 2010 Feb; 53(2):356-68. PubMed ID: 19946662
[TBL] [Abstract][Full Text] [Related]
17. Self-Transducible Bimodal PDX1-FOXP3 Protein Lifts Insulin Secretion and Curbs Autoimmunity, Boosting Tregs in Type 1 Diabetic Mice.
Amatya C; Radichev IA; Ellefson J; Williams M; Savinov AY
Mol Ther; 2018 Jan; 26(1):184-198. PubMed ID: 28988715
[TBL] [Abstract][Full Text] [Related]
18. Transient Depletion of Foxp3
Watts D; Janßen M; Jaykar M; Palmucci F; Weigelt M; Petzold C; Hommel A; Sparwasser T; Bonifacio E; Kretschmer K
Front Immunol; 2021; 12():720133. PubMed ID: 34447385
[TBL] [Abstract][Full Text] [Related]
19. Cyclophosphamide-induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+Foxp3+ regulatory T cells.
Brode S; Raine T; Zaccone P; Cooke A
J Immunol; 2006 Nov; 177(10):6603-12. PubMed ID: 17082572
[TBL] [Abstract][Full Text] [Related]
20. IL-33 Effect on Quantitative Changes of CD4
Ryba-Stanisławowska M; Werner P; Skrzypkowska M; Brandt A; Myśliwska J
Mediators Inflamm; 2016; 2016():9429760. PubMed ID: 27761063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
